spacer
home > ebr > autumn 2017 > unleashing 3d
PUBLICATIONS
European Biopharmaceutical Review

Unleashing 3D

The last 10 years have seen a dramatic surge in the number of publications about organoids – but what are they and why is everyone talking about them? In simple terms, they are miniature organs grown in vitro in a near-physiological 3D environment. Unlike simple tissue cultures, they retain features of the organ they are derived from, including important structural and functional properties, and many believe that they could dramatically accelerate the understanding of human biology and disease progression.

Traditional 2D cell culture has brought great progress in understanding human development over the last 50 years. However, studying organogenesis in vitro has been hindered by the lack of appropriate systems that would allow the cell-to-cell interactions needed for organ formation. Organoids provide the accurate and physiologically relevant models that are needed to overcome this deficiency.

So-called organoids have now been derived from gut, kidney, pancreas, liver and brain tissue, and growing these mini-organs has been made possible by the recent advances in stem cell systems and the development of 3D support matrices. Thanks to this new technology, cells derived from stem cells or organ progenitors can self-organise through cell sorting and recapitulate the complexity of mammalian organogenesis in vitro in a way that is similar to how they do in vivo.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Dr Colin Sanctuary is a biomedical engineer and Chief Executive Officer at QGel. Following his PhD in biomedical engineering at École Polytechnique Fédérale de Lausanne, Switzerland, Colin worked in product development and later in global marketing in the medical device and pharma industries. In 2009, he co-founded QGel with the aim of building a company that contributes to improving R&D productivity in pharma, particularly in the area of developing novel anticancer treatments.
spacer
Dr Colin Sanctuary
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Synpromics Announces Gene Therapy Research Partnership with Solid Biosciences

Edinburgh, UK – September 20th, 2017 - Synpromics Ltd, the leader in gene control, today announces a new research partnership with Solid Biosciences, LLC. Under the terms of the agreement, Synpromics will provide Solid Biosciences access to a set of key muscle-selective promoter candidates to be used in the development of new treatment options for Duchenne muscular dystrophy (DMD).
More info >>

White Papers

Characterisation of Biopharmaceutical Proteins

Reading Scientific Services Ltd (RSSL)

Over the next five years it is anticipated that there is going to be an explosion in the numbers of biosimilar products coming to market as patents expire. Consequently, in line with regulatory guidance, there will be a commensurate need to provide full characterisation of such biopharmaceuticals. The purpose of this article is to describe the array of the more common techniques used in biopharmaceutical characterisation (typically of protein or polypeptide). For full characterisation of a protein, the protein�s primary, secondary and tertiary structure as well as its physiochemical properties should be assessed.
More info >>

 
Industry Events

10th Annual Pre-Filled Syringes Europe 2018

17-18 January 2018, Copthorne Tara Hotel, Kensington, London UK

Join the calendar event highlight for the medical device industry at Europe's leading 10th annual conference and exhibition on Pre-Filled Syringes when it returns to Central London on 17th and 18th January 2018. Pre-Filled Syringes Europe will once again provide a perfect platform to discuss new advancements and showcase the latest innovations to keep you at the forefront of a dynamic and booming market.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement